By Matt Grossman

Bristol-Myers Squibb Co. on Thursday issued stronger earnings guidance for the remainder of 2020 and restated previous guidance for next year as the company delivered earnings and revenue results for the latest quarter that topped analysts' expectations.

Bristol said it now expects a full-year profit of 47 cents a share to 57 cents a share this year, or $6.25 a share to $6.35 a share on an adjusted basis. The company's previous guidance had forecast a result between a loss of 6 cents a share and a profit of 9 cents a share, or a profit of $6.10 a share to $6.25 a share on an adjusted basis.

The New York City-based pharmaceutical company also reiterated a previous forecast for 2021 calling for an adjusted profit of $7.15 a share to $7.45 a share next year.

Bristol's 2021 estimate includes expected dilution from the company's acquisition of MyoKardia Inc., announced last month, the company said.

Write to Matt Grossman at matt.grossman@wsj.com

(END) Dow Jones Newswires

11-05-20 0744ET